drugset / Trial / NCT04815148

MH004 Topical Cream in Healthy Adult Volunteers and Participants With Atopic Dermatitis or Rheumatoid Arthritis

NCT04815148 ↗

Phase 1 Unknown 72 enrolled Minghui Pharmaceutical Pty Ltd
RandomizedSequentialOpen-labelTreatment

Summary

This is a Phase Ia/Ib Study of MH004 in Healthy Adult Volunteers, participants with Mild to Moderate Atopic Dermatitis and participants with Mild to Moderate Rheumatoid Arthritis.

Timeline

Start
2021-04-01
Primary completion
2022-03-31
Completion
2022-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject MH004 Unknown 0.1 % Topical
Subject MH004 Unknown 0.3 % Topical
Subject MH004 Unknown 1 % Topical
Subject MH004 Unknown 3 % Topical